We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

$12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts

News   Mar 25, 2020 | Original story from the University of Saskatchewan

 
$12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts

VIDO-InterVac researchers are working on prototype vaccines to combat the new coronavirus outbreak. Credit: David Stobbe for the University of Saskatchewan

 
 
Advertisement
 

RELATED ARTICLES

Anti-parasitic Drug Eliminates SARS-CoV-2 Within 48 Hours in Cell Culture

News

A Monash University-led study has shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours in cell culture.

READ MORE

Treating COVID-19 in a Patient With Multiple Myeloma – A Case Study

News

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective therapeutic strategy against COVID-19 in infected patients who also have multiple myeloma and other blood cancers.

READ MORE

Sea Sponge Molecule May Stop Cervical Cancer Cell Growth

News

A sponge found in Manado Bay, Indonesia, synthesizes a molecule called manzamine A, which has been shown to stop the growth of cervical cancer cells. The study explored the anti-growth and cancer cell-killing effects of manzamine A in different cervical cancer cell lines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE